Reduced FHIT expression is associated with tumor progression in sporadic colon adenocarcinoma
- 1 February 2014
- journal article
- research article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 96 (1) , 92-97
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Down-regulation of FHIT inhibits apoptosis of colorectal cancer: Mechanism and clinical implicationSurgical Oncology, 2006
- nm23-H1 expression and loss of heterozygosity in colon adenocarcinomaJournal of Clinical Pathology, 2004
- FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significanceClinical Endocrinology, 2000
- Role of FHIT in Human CancerJournal of Clinical Oncology, 1999
- Replacement of Fhit in cancer cells suppresses tumorigenicityProceedings of the National Academy of Sciences, 1997
- Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessmentNature Medicine, 1996
- The FHIT Gene at 3p14.2 Is Abnormal in Lung CancerCell, 1996
- Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancerInternational Journal of Cancer, 1996
- The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract CancersCell, 1996
- Fhit, a Putative Tumor Suppressor in Humans, Is a Dinucleoside 5‘,5‘ ‘‘-P1,P3-Triphosphate HydrolaseBiochemistry, 1996